Original Research Online Publishing Date: | ||||||||||||
A comparative study to evaluate the efficacy of metformin monotherapy on glycemic markers in normal weight, over weight, and obese patients with Type 2 diabetes mellitus Kavyashree A C, Mamatha K, Prabhu S, Laxminarayana Kamath.
|
How to Cite this Article |
Pubmed Style C KA, K M, S P, Kamath L. A comparative study to evaluate the efficacy of metformin monotherapy on glycemic markers in normal weight, over weight, and obese patients with Type 2 diabetes mellitus. Natl J Physiol Pharm Pharmacol. 2022; 12(1): 49-54. doi:10.5455/njppp.2022.12.07252202102082021 Web Style C KA, K M, S P, Kamath L. A comparative study to evaluate the efficacy of metformin monotherapy on glycemic markers in normal weight, over weight, and obese patients with Type 2 diabetes mellitus. https://www.njppp.com/?mno=97607 [Access: March 18, 2024]. doi:10.5455/njppp.2022.12.07252202102082021 AMA (American Medical Association) Style C KA, K M, S P, Kamath L. A comparative study to evaluate the efficacy of metformin monotherapy on glycemic markers in normal weight, over weight, and obese patients with Type 2 diabetes mellitus. Natl J Physiol Pharm Pharmacol. 2022; 12(1): 49-54. doi:10.5455/njppp.2022.12.07252202102082021 Vancouver/ICMJE Style C KA, K M, S P, Kamath L. A comparative study to evaluate the efficacy of metformin monotherapy on glycemic markers in normal weight, over weight, and obese patients with Type 2 diabetes mellitus. Natl J Physiol Pharm Pharmacol. (2022), [cited March 18, 2024]; 12(1): 49-54. doi:10.5455/njppp.2022.12.07252202102082021 Harvard Style C, K. A., K, . M., S, . P. & Kamath, . L. (2022) A comparative study to evaluate the efficacy of metformin monotherapy on glycemic markers in normal weight, over weight, and obese patients with Type 2 diabetes mellitus. Natl J Physiol Pharm Pharmacol, 12 (1), 49-54. doi:10.5455/njppp.2022.12.07252202102082021 Turabian Style C, Kavyashree A, Mamatha K, Prabhu S, and Laxminarayana Kamath. 2022. A comparative study to evaluate the efficacy of metformin monotherapy on glycemic markers in normal weight, over weight, and obese patients with Type 2 diabetes mellitus. National Journal of Physiology, Pharmacy and Pharmacology, 12 (1), 49-54. doi:10.5455/njppp.2022.12.07252202102082021 Chicago Style C, Kavyashree A, Mamatha K, Prabhu S, and Laxminarayana Kamath. "A comparative study to evaluate the efficacy of metformin monotherapy on glycemic markers in normal weight, over weight, and obese patients with Type 2 diabetes mellitus." National Journal of Physiology, Pharmacy and Pharmacology 12 (2022), 49-54. doi:10.5455/njppp.2022.12.07252202102082021 MLA (The Modern Language Association) Style C, Kavyashree A, Mamatha K, Prabhu S, and Laxminarayana Kamath. "A comparative study to evaluate the efficacy of metformin monotherapy on glycemic markers in normal weight, over weight, and obese patients with Type 2 diabetes mellitus." National Journal of Physiology, Pharmacy and Pharmacology 12.1 (2022), 49-54. Print. doi:10.5455/njppp.2022.12.07252202102082021 APA (American Psychological Association) Style C, K. A., K, . M., S, . P. & Kamath, . L. (2022) A comparative study to evaluate the efficacy of metformin monotherapy on glycemic markers in normal weight, over weight, and obese patients with Type 2 diabetes mellitus. National Journal of Physiology, Pharmacy and Pharmacology, 12 (1), 49-54. doi:10.5455/njppp.2022.12.07252202102082021 |